Clinical Trial Update: Observational Registry of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

View source ↗

Summary

An observational registry evaluating NovoSeven as on-demand treatment for bleeds in patients with Hemophilia A or B with inhibitors; the study is completed and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Bleeding Disorder
• Hemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Status: COMPLETED | Results posted: 2011-12-19